(Q36613378)

15 August 2017

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis (English)

1 reference

15 August 2017

7

Hans-Peter Hartung

1 reference

15 August 2017

14

Ludwig Kappos

1 reference

15 August 2017

10

Frederik Barkhof

1 reference

15 August 2017

8

David H Miller

1 reference

15 August 2017

3

Pasquale Calabrese

1 reference

15 August 2017

Iris-Katharina Penner

1

1 reference

15 August 2017

Brigitte Stemper

2

1 reference

15 August 2017

Mark S Freedman

4

1 reference

15 August 2017

Chris H Polman

5

1 reference

15 August 2017

Gilles Edan

6

1 reference

15 August 2017

Xavier Montalbán

9

1 reference

15 August 2017

Dirk Pleimes

11

1 reference

15 August 2017

Vivian Lanius

12

1 reference

15 August 2017

Christoph Pohl

13

1 reference

15 August 2017

Rupert Sandbrink

15

1 reference

15 August 2017

4 April 2012

1 reference

Multiple Sclerosis Journal

15 August 2017

1 reference

15 August 2017

18

1 reference

15 August 2017

10

1 reference

15 August 2017

1466-1471

1 reference

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Early cognitive impairment in patients with clinically isolated syndrome suggestive of multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Cognitive impairment in probable multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Neuropsychologic status in multiple sclerosis after treatment with glatiramer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Cognitive impairment in different MS subtypes and clinically isolated syndromes

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3573673

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1352458512442438

Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22492127

12 December 2020

inferred from PubMed ID database lookup

Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22492127

12 December 2020

inferred from PubMed ID database lookup

Cognitive impairment in multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22492127

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1177/1352458512442438

1 reference

release_475qzimghrel5d4ye3ywtxz2ly

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/475qzimghrel5d4ye3ywtxz2ly

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

22492127

1 reference